Related Experiment Video
Updated: Oct 26, 2025

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
Mechanisms of organophosphate neurotoxicity
1Department of Molecular Sciences, University of California, Davis School of Veterinary Medicine, 1089 Veterinary Medicine Drive, Davis, CA, 95616, USA.
Abstract:
The canonical mechanism of organophosphate (OP) neurotoxicity is the inhibition of acetylcholinesterase (AChE). However, multiple lines of evidence suggest that mechanisms in addition to or other than AChE inhibition contribute to the neurotoxic effects associated with acute and chronic OP exposures. Characterizing the role(s) of AChE inhibition versus noncholinergic mechanisms in OP neurotoxicity remains an active area of research with significant diagnostic and therapeutic implications. Here, we review recently published studies that provide mechanistic insights regarding (1) OP-induced status epilepticus, (2) long-term neurologic consequences of acute OP exposures, and (3) neurotoxic effects associated with repeated low-level OP exposures. Key data gaps and challenges are also discussed.
Insights
Organophosphate (OP) neurotoxicity involves more than just acetylcholinesterase (AChE) inhibition. Research explores noncholinergic mechanisms contributing to acute and chronic OP poisoning effects.
Area of Science:
- Neuroscience
- Toxicology
- Biochemistry
Background:
- Organophosphate (OP) compounds are widely used pesticides and chemical warfare agents.
- The primary known mechanism of OP neurotoxicity is the inhibition of acetylcholinesterase (AChE), an enzyme crucial for nerve function.
- Emerging evidence suggests noncholinergic pathways also contribute significantly to OP-induced neurotoxicity.
Purpose of the Study:
- To review recent studies on the mechanistic insights into OP neurotoxicity.
- To elucidate the roles of AChE inhibition versus noncholinergic mechanisms in OP-induced neurotoxic effects.
- To highlight data gaps and challenges in understanding OP neurotoxicity.
Main Methods:
- Literature review of recently published studies.
- Analysis of mechanistic insights into OP neurotoxicity.
- Synthesis of findings related to OP-induced status epilepticus, long-term consequences, and repeated low-level exposures.
Main Results:
- OPs can induce status epilepticus through mechanisms beyond AChE inhibition.
- Acute OP exposure can lead to long-term neurological deficits.
- Repeated low-level OP exposures exhibit distinct neurotoxic effects.
Conclusions:
- AChE inhibition is not the sole determinant of OP neurotoxicity.
- Noncholinergic mechanisms are critical for understanding the full spectrum of OP neurotoxic effects.
- Further research is needed to address key data gaps for improved diagnostics and therapeutics.
Related Concept Videos
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...

